Serum FGF-23 levels have been reported to increase in the very early stages of CKD, and the increase may represent a long-term, delayed response to transient episodes of hyperphosphatemia occurring in the early stage of CKD, possibly when the rapid response of PTH is becoming insufficient. The gene discussed is FGF23; the disease is hyperphosphatemia.